Surprisingly, glucagon, which is used to treat severe hypoglycemia by targeting the glucagon receptor and is a weak agonist for GLP-1R26, was also found to activate a subset of the pathways elicited by GLP-1 (7-36) stimulation5, underlining the importance of investigating polypharmacology. Here, GCGR is linked to Hypoglycemia.